GGrantIndex
← Search

ANTI-CD40 LIGAND THERAPY FOR SLOWING PROGRESSION AND EXTENDING LIFE IN AMYOTROPHIC LATERAL SCLEROSIS

$645,900FY2017Department of the ArmyDOD

Als Therapy Development Fnd

Investigators

View source on USAspending →
ANTI-CD40 LIGAND THERAPY FOR SLOWING PROGRESSION AND EXTENDING LIFE IN AMYOTROPHIC LATERAL SCLEROSIS · GrantIndex